The Effect of Amantadine on Post-COVD-19 Fatigue

"Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Drug B10-FC After Single Administration to Adult Patients".

NCT07156864 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Study of Oral High/Low-dose Cepharanthine Compared With Placebo in Non Hospitalized Adults With COVID-19

NCT05398705 ·Status: COMPLETED ·Phase: PHASE2

Factorial Randomized Trial of Rendesivir and Baricitinib Plus Dexamethasone for COVID-19 (the AMMURAVID Trial)

NCT04832880 ·Status: UNKNOWN ·Phase: PHASE3

The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection

NCT04360980 ·Status: COMPLETED ·Phase: PHASE2

Nicotinamide-based Supportive Therapy in Lymphopenia for Patients With COVID-19

NCT04910230 ·Status: COMPLETED ·Phase: NA

Umifenovir in Hospitalized COVID-19 Patients

NCT04350684 ·Status: UNKNOWN ·Phase: PHASE4

A Clinical Study to Evaluate the Efficacy and Safety of SIM0417 Orally Co-Administered With Ritonavir in Symptomatic Adult Participants With Mild to Moderate COVID-19

NCT05506176 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study Evaluating SHEN26 Capsule in Patients With Mild to Moderate COVID-19

NCT05908071 ·Status: UNKNOWN ·Phase: PHASE3

Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19

NCT04528667 ·Status: COMPLETED ·Phase: PHASE2

Safety and Pharmacokinetic Effects of Oseltamivir Alone or in Combination With Amantadine

NCT00416962 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients

NCT04409522 ·Status: UNKNOWN ·Phase: NA

Safety and Efficacy of Medications COVID-19

NCT05596617 ·Status: COMPLETED ·Phase: NA

Study of SHEN26 Capsule in Patients With Mild to Moderate COVID-19

NCT05676073 ·Status: COMPLETED ·Phase: PHASE2

COVID-19 Huashi Baidu Formula Clinical Study

NCT05638672 ·Status: UNKNOWN ·Phase: NA

NanoMn®_COVID-19 A Prospective, Multicenter, Randomized, Placebo-controlled, Parallel-group, Double-blind Trial to Evaluate the Clinical Efficacy of NanoManganese® on Top of Standard of Care, in Adult Patients With Moderate to Severe Coronavirus Disease 2019 (COVID-19)

NCT05451654 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A First-In-Human Phase 1b Study of AmnioPul-02 in COVID-19 / Other LRTI

NCT05348772 ·Status: COMPLETED ·Phase: PHASE1

Homeopathic Treatment of Post-acute COVID-19 Syndrome

NCT05104749 ·Status: COMPLETED ·Phase: PHASE3

First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.

NCT04535167 ·Status: COMPLETED ·Phase: PHASE1

Study of HS-10517 in Chinese Adult Participants

NCT05779579 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19

NCT04389944 ·Status: COMPLETED ·Phase: NA

Famotidine vs Placebo for the Treatment of Non-Hospitalized Adults With COVID-19

NCT04724720 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (Phase3)

NCT05084911 ·Status: COMPLETED ·Phase: PHASE3

Application of Desferal to Treat COVID-19

NCT04333550 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Сlinical Trial of Efficacy and Safety of Prospekta in the Treatment of Post-COVID-19 Asthenia.

NCT05074888 ·Status: COMPLETED ·Phase: PHASE3

Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.

NCT05785390 ·Status: TERMINATED ·Phase: PHASE2